The Epoch Times
By
November 17, 2021 Updated: November 17, 2021
U.S. drug regulators will decide whether to greenlight booster doses of Pfizer’s COVID-19 vaccine for all Americans 16 or older without convening its expert vaccine advisory panel, the Food and Drug Administration (FDA) confirmed to The Epoch Times on Wednesday.
FDA’s acting head and other top Biden administration officials said earlier this year that booster doses should be given to all because of waning vaccine efficacy against the virus that causes COVID-19.